BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aird, E G
Right arrow Articles by Joiner, M C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aird, E G
Right arrow Articles by Joiner, M C
British Journal of Radiology 74 (2001),56-61 © 2001 The British Institute of Radiology

Full paper

A purpose-built iodine-125 irradiation plaque for low dose rate low energy irradiation of cell lines in vitro

E G Aird, PhD, FIPEM 1 M Folkard, BSc, PhD 2 C R Mayes, BSc 2 P J Bownes, BSc, MSc 1 J M Lawson, BSc, MSc 1 and M C Joiner, MA, PhD 2

1 Medical Physics Department, Mount Vernon Hospital, Northwood, Middlesex, HA6 2RN 2 Gray Laboratory Cancer Research Trust, PO Box 100, Mount Vernon Hospital, Northwood, Middlesex, HA6 2JR, UK

The phenomenon of hyper-radiosensitivity (HRS) to very low acute single doses of radiation has been demonstrated in several cell lines in vitro and in vivo, and has been studied in theory and in practice. The theory suggests a similar hypersensitivity when cells are continuously exposed to radiation at very low dose rates. These low dose rates are used when radioactive seed (iodine-125 or palladium-103) implants of the prostate are used as an alternative to surgery or external beam radiotherapy. To investigate the radiobiology of hypersensitivity of this type on various cell lines in vitro, an iodine-125 seed irradiator has been designed and built for safe use in the Gray Laboratory. In practice, the calculated dose rate has been used for consistency. Discrepancies between calculated and measured dose rates are discussed.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Y. Liu, J.-l. Liu, Z.-z. Cai, Z. Lu, Y.-h. Dong, Z.-s. Li, Y.-f. Gong, and X.-h. Man
A Novel Approach for Treatment of Unresectable Pancreatic Cancer: Design of Radioactive Stents and Trial Studies on Normal Pigs
Clin. Cancer Res., June 1, 2007; 13(11): 3326 - 3332.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2001 by the British Institute of Radiology.